Marshall Lerner delivered a presentation to a group of undergraduate, doctoral and postdoctoral students in the Chemistry Department of Harvard University about the CRISPR patent litigation and the use of CRISPR in eukaryotic cells. Mr. Lerner did a presentation in 2018 when the litigation was in the Patent Office and a follow-up presentation on February 11, 2019, after the Patent Office decision was affirmed on appeal. A CRISPR-Cas9 system is a combination of protein and […]

Read More